TY - JOUR
T1 - The opportunity for greater patient and public involvement and engagement in drug development and regulation
AU - Aiyegbusi, Olalekan Lee
AU - Cruz Rivera, Samantha
AU - Oliver, Kathy
AU - Manna, Elaine
AU - Collis, Phil
AU - King-Kallimanis, Bellinda L.
AU - Bhatnagar, Vishal
AU - Herold, Ralf
AU - Hopkins, Jon
AU - Campbell, Lisa
AU - Croker, Alysha
AU - Leach, Myles
AU - Calvert, Melanie
PY - 2023/5
Y1 - 2023/5
N2 - Patients and the wider public are beneficiaries of scientific research that leads to new drugs and medical technologies, but they can and should be able to contribute to these advances through participation in clinical studies, co-design of research and input into regulatory processes.
AB - Patients and the wider public are beneficiaries of scientific research that leads to new drugs and medical technologies, but they can and should be able to contribute to these advances through participation in clinical studies, co-design of research and input into regulatory processes.
U2 - 10.1038/d41573-023-00031-x
DO - 10.1038/d41573-023-00031-x
M3 - Comment/debate
SN - 1474-1776
VL - 22
SP - 337
EP - 338
JO - Nature reviews. Drug discovery
JF - Nature reviews. Drug discovery
IS - 5
ER -